DRGEM Corporation - Asset Resilience Ratio
DRGEM Corporation (263690) has an Asset Resilience Ratio of 1.34% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2025)
This chart shows how DRGEM Corporation's Asset Resilience Ratio has changed over time. Check DRGEM Corporation PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down DRGEM Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is DRGEM Corporation worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩1.72 Billion | 1.34% |
| Total Liquid Assets | ₩1.72 Billion | 1.34% |
Asset Resilience Insights
- Limited Liquidity: DRGEM Corporation maintains only 1.34% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
DRGEM Corporation Industry Peers by Asset Resilience Ratio
Compare DRGEM Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Bactiguard Holding AB (publ)
ST:BACTI-B |
Medical Devices | 8.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
Annual Asset Resilience Ratio for DRGEM Corporation (2015–2025)
The table below shows the annual Asset Resilience Ratio data for DRGEM Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.00% | ₩2.43 Billion ≈ $1.65 Million |
₩121.97 Billion ≈ $82.65 Million |
-11.76pp |
| 2024-12-31 | 13.76% | ₩16.78 Billion ≈ $11.37 Million |
₩122.00 Billion ≈ $82.68 Million |
-0.98pp |
| 2023-12-31 | 14.73% | ₩18.92 Billion ≈ $12.82 Million |
₩128.41 Billion ≈ $87.02 Million |
-8.47pp |
| 2022-12-31 | 23.20% | ₩29.39 Billion ≈ $19.92 Million |
₩126.71 Billion ≈ $85.87 Million |
-3.16pp |
| 2021-12-31 | 26.36% | ₩22.16 Billion ≈ $15.01 Million |
₩84.05 Billion ≈ $56.96 Million |
+0.10pp |
| 2020-12-31 | 26.26% | ₩19.07 Billion ≈ $12.92 Million |
₩72.63 Billion ≈ $49.22 Million |
+8.21pp |
| 2019-12-31 | 18.04% | ₩11.38 Billion ≈ $7.71 Million |
₩63.05 Billion ≈ $42.73 Million |
-2.62pp |
| 2018-12-31 | 20.66% | ₩9.56 Billion ≈ $6.48 Million |
₩46.29 Billion ≈ $31.37 Million |
+8.77pp |
| 2017-12-31 | 11.89% | ₩4.09 Billion ≈ $2.77 Million |
₩34.41 Billion ≈ $23.32 Million |
+1.16pp |
| 2016-12-31 | 10.73% | ₩2.99 Billion ≈ $2.02 Million |
₩27.82 Billion ≈ $18.85 Million |
+10.73pp |
| 2015-12-31 | 0.00% | ₩11.00K ≈ $7.45 |
₩23.54 Billion ≈ $15.95 Million |
-- |
About DRGEM Corporation
DRGEM Corporation manufactures and sells diagnostic radiography systems. It offers high frequency X-ray generators; conventional and digital radiography systems; and ACQUIDR, a digital imaging system. DRGEM Corporation exports its products. The company was founded in 2003 and is headquartered in Gwangmyeong-si, South Korea.